Bausch Health Companies Inc. (TSX:BHC)
7.25
-0.08 (-1.09%)
Mar 9, 2026, 4:00 PM EST
Bausch Health Companies Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 157 | -46 | -592 | -225 | -948 | Upgrade
|
| Depreciation & Amortization | 1,208 | 1,267 | 1,264 | 1,394 | 1,552 | Upgrade
|
| Other Amortization | 94 | 55 | 65 | 99 | 55 | Upgrade
|
| Loss (Gain) From Sale of Assets | -6 | -10 | -3 | -5 | 86 | Upgrade
|
| Asset Writedown & Restructuring Costs | 153 | 29 | 547 | 839 | 615 | Upgrade
|
| Stock-Based Compensation | 216 | 150 | 132 | 126 | 128 | Upgrade
|
| Provision & Write-off of Bad Debts | 71 | 62 | 56 | 51 | 60 | Upgrade
|
| Other Operating Activities | -274 | 83 | 145 | -2,611 | 6 | Upgrade
|
| Change in Accounts Receivable | -134 | -216 | -195 | -57 | -229 | Upgrade
|
| Change in Inventory | -12 | -267 | -322 | -198 | -16 | Upgrade
|
| Change in Accounts Payable | -76 | 357 | 158 | -75 | 121 | Upgrade
|
| Change in Other Net Operating Assets | 3 | 133 | -223 | -66 | -4 | Upgrade
|
| Operating Cash Flow | 1,400 | 1,597 | 1,032 | -728 | 1,426 | Upgrade
|
| Operating Cash Flow Growth | -12.34% | 54.75% | - | - | 28.35% | Upgrade
|
| Capital Expenditures | -397 | -337 | -215 | -218 | -269 | Upgrade
|
| Sale of Property, Plant & Equipment | 7 | 7 | 5 | 5 | 669 | Upgrade
|
| Cash Acquisitions | -204 | -136 | -1,890 | -45 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -10 | -3 | -57 | -50 | -14 | Upgrade
|
| Investment in Securities | -3 | 2 | -1 | 5 | -4 | Upgrade
|
| Other Investing Activities | 12 | 13 | 13 | - | 27 | Upgrade
|
| Investing Cash Flow | -595 | -454 | -2,145 | -303 | 409 | Upgrade
|
| Long-Term Debt Issued | 10,554 | 661 | 3,291 | 6,836 | 2,100 | Upgrade
|
| Total Debt Issued | 10,554 | 661 | 3,291 | 6,836 | 2,100 | Upgrade
|
| Long-Term Debt Repaid | -11,191 | -1,460 | -1,710 | -7,846 | -3,440 | Upgrade
|
| Total Debt Repaid | -11,191 | -1,460 | -1,710 | -7,846 | -3,440 | Upgrade
|
| Net Debt Issued (Repaid) | -637 | -799 | 1,581 | -1,010 | -1,340 | Upgrade
|
| Repurchase of Common Stock | -24 | -26 | -24 | -31 | -52 | Upgrade
|
| Other Financing Activities | -81 | -43 | -82 | 567 | -121 | Upgrade
|
| Financing Cash Flow | -742 | -868 | 1,475 | -474 | -1,513 | Upgrade
|
| Foreign Exchange Rate Adjustments | 61 | -36 | 9 | -23 | -19 | Upgrade
|
| Net Cash Flow | 124 | 239 | 371 | -1,528 | 303 | Upgrade
|
| Free Cash Flow | 1,003 | 1,260 | 817 | -946 | 1,157 | Upgrade
|
| Free Cash Flow Growth | -20.40% | 54.22% | - | - | 43.02% | Upgrade
|
| Free Cash Flow Margin | 9.77% | 13.09% | 9.33% | -11.64% | 13.72% | Upgrade
|
| Free Cash Flow Per Share | 2.67 | 3.42 | 2.24 | -2.61 | 3.22 | Upgrade
|
| Cash Interest Paid | 1,810 | 1,674 | 1,533 | 1,540 | 1,419 | Upgrade
|
| Cash Income Tax Paid | 163 | 61 | 237 | 266 | 240 | Upgrade
|
| Levered Free Cash Flow | 1,087 | 1,721 | 738.13 | 1,017 | 1,627 | Upgrade
|
| Unlevered Free Cash Flow | 1,995 | 2,533 | 1,503 | 1,833 | 2,464 | Upgrade
|
| Change in Working Capital | -219 | 7 | -582 | -396 | -128 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.